FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Synageva BioPharma Completes Rolling Submission Of Biologics License Application To The FDA For Sebelipase Alfa And Submits Marketing Authorization Application To European Medicines Agency
December 02, 2014
Synageva BioPharma Presents New Data From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency At The AASLD Meeting
November 10, 2014
Synageva BioPharma Reports Third Quarter 2014 Financial Results
October 30, 2014
Synageva BioPharma to Present at the Nomura Biotechnology Conference
October 29, 2014
Synageva BioPharma Starts Rolling Submission Of A Biologics License Application To The FDA For Sebelipase Alfa
October 21, 2014
Sebelipase Alfa Phase 3 Data In Children And Adults With LAL Deficiency Selected For Oral Presentation During The Late-Breaking Session At The Liver Meeting®
October 08, 2014
Synageva BioPharma Appoints Robert Bazemore As Chief Operating Officer
September 22, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here